Antituberculosis Drug-Induced Liver Injury with Autoimmune Features: Facing Diagnostic and Treatment Challenges
The authors present a case report of antituberculosis drug-induced liver injury that offered diagnostic challenges (namely, the possibility of drug-induced autoimmune hepatitis) and treatment difficulties.
Main Authors: | Maria Adriana Rangel, Isabel Pinto Pais, Raquel Duarte, Isabel Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2017/5741896 |
Similar Items
-
USE OF CHOLUDEXAN TO TREAT ANTITUBERCULOSIS DRUG-INDUCED LIVER INJURY 1
by: A. V. Mordyk, et al.
Published: (2014-02-01) -
Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury
by: Liu YH, et al.
Published: (2021-09-01) -
Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
by: Qiang Su, et al.
Published: (2021-01-01) -
The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury
by: Jingwei Zhang, et al.
Published: (2019-01-01) -
Burden of antituberculosis and antiretroviral drug-induced liver injury at a secondary hospital in South Africa
by: Schutz, Charlotte
Published: (2015)